Demand for Artemisinin Combination Therapy in UK

Demand for Artemisinin Combination Therapy in UK Size and Share Forecast Outlook 2026 to 2036

Demand for artemisinin combination therapy in UK is projected to grow from USD 45.2 million in 2026 to USD 91.8 million by 2036, at a CAGR of 7.3%. Artemether + Lumefantrine will dominate with a 42.5% market share, while nhs hospitals and specialist clinics will lead the distribution channel segment with a 48.7% share.

Demand for Artemisinin Combination Therapy in UK
  • FACT12674MR
  • 16 Dec 2025
  • Healthcare
  • 170 Pages
  • 06 Tables
  • 21 Figures

Table of Content

  1. Executive Summary
    • UK Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. UK Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y to o to Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. UK Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
  6. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Product
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product, 2026 to 2036
      • Artemether + Lumefantrine
      • Artesunate + Amodiaquine
      • Dihydroartemisinin + Piperaquine
      • Artesunate + Mefloquine
      • Pyronaridine + Artesunate
      • Others
    • Y to o to Y Growth Trend Analysis By Product, 2021 to 2025
    • Absolute $ Opportunity Analysis By Product, 2026 to 2036
  7. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Distribution Channel
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Distribution Channel, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Distribution Channel, 2026 to 2036
      • NHS Hospitals and Specialist Clinics
      • Private Healthcare Facilities
      • Travel Medicine Centers
      • Others
    • Y to o to Y Growth Trend Analysis By Distribution Channel, 2021 to 2025
    • Absolute $ Opportunity Analysis By Distribution Channel, 2026 to 2036
  8. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • UK
    • Market Attractiveness Analysis By Region
  9. UK Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Product
      • By Distribution Channel
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Distribution Channel
    • Key Takeaways
  10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Product
      • By Distribution Channel
  11. Competition Analysis
    • Competition Deep Dive
      • Novartis AG
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Sanofi S.A.
      • Cipla Limited
      • KPC Pharmaceuticals Incorporated
      • Fosun Pharmaceutical (Guilin Pharma) Company Limited
      • Ajanta Pharma Limited
      • Ipca Laboratories Limited
      • Desano Incorporated
      • Hovid Berhad
      • Mylan N.V.
  12. Assumptions & Acronyms Used
  13. Research Methodology

List Of Table

  • Table 1: UK Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: UK Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 3: UK Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036
  • Table 4: UK Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 5: UK Market Value (USD Million) Forecast by Product, 2021 to 2036
  • Table 6: UK Market Value (USD Million) Forecast by Distribution Channel, 2021 to 2036

List Of Figures

  • Figure 1: UK Market Pricing Analysis
  • Figure 2: UK Market Value (USD Million) Forecast 2021 to 2036
  • Figure 3: UK Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 4: UK Market Y to o to Y Growth Comparison by Product, 2026 to 2036
  • Figure 5: UK Market Attractiveness Analysis by Product
  • Figure 6: UK Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 7: UK Market Y to o to Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 8: UK Market Attractiveness Analysis by Distribution Channel
  • Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2026 to 2036
  • Figure 11: UK Market Attractiveness Analysis by Region
  • Figure 12: UK Market Incremental Dollar Opportunity, 2026 to 2036
  • Figure 13: UK Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 14: UK Market Value Share and BPS Analysis by Product, 2026 and 2036
  • Figure 15: UK Market Y to o to Y Growth Comparison by Product, 2026 to 2036
  • Figure 16: UK Market Attractiveness Analysis by Product
  • Figure 17: UK Market Value Share and BPS Analysis by Distribution Channel, 2026 and 2036
  • Figure 18: UK Market Y to o to Y Growth Comparison by Distribution Channel, 2026 to 2036
  • Figure 19: UK Market Attractiveness Analysis by Distribution Channel
  • Figure 20: UK Market - Tier Structure Analysis
  • Figure 21: UK Market - Company Share Analysis

Demand for Artemisinin Combination Therapy in UK